麦胶性肠病并发非酒精性脂肪肝1例报告

doi:10.3969/j.issn.1672-5069.2018.06.039

Abstract

Pu Yonglan, Chen Yuanwen, Fan Jiangao.. Gluten intestinal disease and nonalcoholic fatty liver: One case report[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 981-982.

[1] 江登丰,乳糜泻研究进展. 胃肠病学和肝病学杂志,2010,19:478-481.
[2] Ludvigsson J F,Rubio-Tapia A,Van Dyke C T,et al. Increasing incidence of celiac disease in a North American population.Am J Gastroenterol,2013,108(5):818-824.
[3] Cataldo F,Montalto G.Celiac disease in the developing countries:a new and challenging public health problem. World J Gastroenterol,2007,13(15):2153-2159.
[4] 王歆琼,刘伟,徐俊杰,等.乳糜泻在中国慢性腹泻患儿中的发病情况.中华儿科杂志,2010,48:244-248.
[5] 王红玲,罗琳洁,寇继光,等. 中国湖北地区腹泻型肠易激综合征患者中成人乳糜泻血清学筛查. 中华内科杂志,2013,52(1):38-41.
[6] Vazquez-Roque MI,Camilleri M,Carlson P,et al.HLA-DQ genotype is associated with accelerated small bowel transit in patients with diarrhea-predominant irritable bowel syndrome. Eur J Gastroenterol Hepatol,2011,23:481-487.
[7] Nehra V,Angulo P,Buchman AL,et al.Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis. Dig Dis Sci,2001,46:2347-2352.
[8] Bakhshipour A,Kaykhaei MA,Moulaei N,et al.Prevalence of coeliac disease in patients with non-alcoholic fatty liver disease. Arab J Gastroenterol,2013,14:113-115.
[9] Reilly NR,Lebwohl B,Hultcrantz R,et al.Increased risk of non alcoholic fatty liver disease after diagnosis of celiac disease. J Hepatol,2015,62:1405-1411.
[10] Rubio-Tapia A,Hill ID,Kelly CP,et al.ACG clinical guidelines:diagnosis and management of celiac disease. Am J Gastroenterol,2013,108:656-676.
[11] Alberto RT,Joseph AM.Classification and management of refractory celiac disease. Gut,2010,59:547-557.
[12] Malamut G,Murray JA,Cellier C.Refractory celiac disease. Gastro intest Endosc Clin N Am,2012,22:759-772.
[13] Simpson S,Thompson T.Nutrition assessment in celiac disease. Gastro intest Endosc Clin N Am,2012,22:797-809.
[14] 李融融,于康. 全程营养管理改善乳糜泻患者结局.协和医学杂志,2015,6(4):255.
[15] Gottlieb K,Dawson J,Hussain F,et al.Development of drugs for celiac disease:review of endpoints for Phase 2 and 3 trials. Gastroenterol Rep(Oxf),2015,3(2):91-102.

Gluten intestinal disease and nonalcoholic fatty liver: One case report

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Zhang Rui, Wang Jian, Chen Shiyao.. Mechanism of portal vein thrombosis in cirrhotic patients with portal hypertension and the treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 930-933.
[6]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[7]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[8]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[9]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[10]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[11]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[12]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[13]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[14]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.
[15]	Zhang Junfei, Xu Heming, Song Haiyan, et al. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome:poor diagnostic sensitivity of Paris' criteria in Chinese patients [J]. Journal of Practical Hepatology, 2019, 22(4): 537-540.